15,863 reports of this reaction
19.4% of all DARBEPOETIN ALFA reports
#1 most reported adverse reaction
DEATH is the #1 most commonly reported adverse reaction for DARBEPOETIN ALFA, manufactured by Amgen, Inc. There are 15,863 FDA adverse event reports linking DARBEPOETIN ALFA to DEATH. This represents approximately 19.4% of all 81,618 adverse event reports for this drug.
Patients taking DARBEPOETIN ALFA who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a frequently reported adverse event for DARBEPOETIN ALFA, accounting for a significant proportion of all reports.
In addition to death, the following adverse reactions have been reported for DARBEPOETIN ALFA:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 15,863 FDA reports for DARBEPOETIN ALFA. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 19.4% of all adverse event reports for DARBEPOETIN ALFA, making it one of the most commonly reported side effect.
If you experience death while taking DARBEPOETIN ALFA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.